ribavirin has been researched along with Hepatitis B, Chronic in 130 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (4.62) | 18.2507 |
| 2000's | 73 (56.15) | 29.6817 |
| 2010's | 50 (38.46) | 24.3611 |
| 2020's | 1 (0.77) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, CJ; Shih, YF | 1 |
| Fernández-Cuenca, F; López-Hernández, I; Paniagua-García, M; Ríos-Villegas, MJ | 1 |
| Lin, HC; Su, CW; Yang, YY | 1 |
| Antón, MD; Ferrando, I; Latorre, P; Moreno Osset, E; Pascual, A; Polanco, A | 1 |
| Asim, M; Jamil, A; Majeed, A; Rashid, A; Razak, S; Wahid, M | 1 |
| Lomonosova, E; Tavis, JE | 1 |
| Hoan, NX; Meyer, CG; Song, LH; Tong, HV; Velavan, TP | 1 |
| Jang, H; Jin, YJ; Kim, CW; Kim, L; Yoon, CH | 1 |
| Asim, M; Khan, A; Rashid, A | 1 |
| Angelico, M; Antonucci, F; Armenia, D; Bellocchi, MC; Carioti, L; Ceccherini-Silberstein, F; Cento, V; Ciancio Manuelli, M; De Leonardis, F; Lenci, I; Manzia, TM; Milana, M; Perno, CF; Sforza, D; Sorbo, MC; Tisone, G | 1 |
| Jia, JD; Rakhda, MI; Wang, TI; Zhao, XY | 1 |
| Aghemo, A; Colombo, M; Degasperi, E; Lampertico, P; Viganò, M | 1 |
| Coton, T; Diallo, I | 1 |
| Akyuz, F; Badur, S; Baran, B; Demir, K; Ermis, F; Gulluoglu, M; Kaymakoglu, S; Simsek, BP; Uyanikoglu, A | 1 |
| Chen, PJ; Chu, YT; Kuo, RN; Lai, MS; Liu, CJ; Shau, WY | 1 |
| Akriviadis, E; Choksi, S; Goulis, I; Ilonidis, G; Pachiadakis, I | 1 |
| Aghemo, A; Colombo, M | 1 |
| Chen, DS; Chen, PJ; Chen, TC; Cheng, HR; Kao, JH; Liu, CH; Liu, CJ; Su, TH; Tseng, TC; Wu, HL | 1 |
| Beinhardt, S; Ferenci, P; Hofer, H; Rutter, K; Scherzer, T; Stättermayer, AF | 1 |
| Chen, PJ; Liu, CJ | 1 |
| Cao, GW; Lin, J; Wu, JF; Zhang, HW; Zhang, Q | 1 |
| Kekez, AJ | 2 |
| Takahashi, T | 1 |
| El-Shabrawi, M; Hassanin, F | 1 |
| Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Liang, PC; Lin, YH; Lin, ZY; Yeh, ML; Yu, ML | 1 |
| Kurmanova, GM; Kurmanova, KB; Sadykova, ShS | 1 |
| Arain, SR; Umer, TP | 1 |
| Pedersen, C; Pedersen, CR | 1 |
| Bani-Sadr, F; Cacoub, P; Carrat, F; Goderel, I; Larrat, S; Lunel-Fabiani, F; Martha, B; Morand, P; Payan, C; Perronne, C; Piroth, L; Pol, S | 1 |
| Kristian, P; Pellová, A; Porubcin, S; Schréter, I | 1 |
| Raimondo, G; Saitta, C | 1 |
| Lee, YJ | 1 |
| Coffin, CS; Terrault, NA | 1 |
| Benito-Martínez, S; González-Mateos, F; Larrubia, JR; Miquel-Plaza, J; Parra, T; Sanz-de-Villalobos, E | 1 |
| Coppola, N; Iodice, V; Macera, M; Piccinino, F; Sagnelli, E; Stanzione, M; Tonsiello, G | 1 |
| Jaklin Kekez, A | 1 |
| Berbara, D; Isla, R; Manero, E | 1 |
| Negro, F | 1 |
| Doo, EC; Jacobson, IM; Murray, JS; Perrillo, RP; Peters, MG; Ross, DB; Wong, JB | 1 |
| Akdogan, M; Cakaloglu, Y; Ferenci, P; Hansen, BE; Janssen, HL; Ormeci, N; Raptopoulou-Gigi, M; Rijckborst, V; Simon, K; Tabak, F; ter Borg, MJ; van Vuuren, AJ; Verhey, E; Zondervan, PE | 1 |
| Chao, YC; Chen, CH; Chen, CL; Chen, DS; Chen, PJ; Chuang, WL; Dai, CY; Hu, TH; Huang, JF; Hung, CH; Kao, JH; Kuo, HT; Lai, MY; Lee, CM; Liao, LY; Lin, ZY; Liu, CH; Liu, CJ; Lu, SN; Su, TH; Tung, SY; Wang, JH; Wu, SS; Yang, SS; Yu, ML | 1 |
| Ciancio, A; Rizzetto, M | 1 |
| Fehér, J; Lengyel, G | 2 |
| Mendes-Corrêa, M; Núñez, M | 1 |
| Dienstag, JL | 1 |
| Mederacke, I; Meyer-Olson, D; Wedemeyer, H; Witte, T | 1 |
| Gonzalez, SA; Keeffe, EB | 1 |
| Bob, F; Bozdog, G; Cioca, D; Curescu, M; Gadalean, F; Gluhovschi, C; Gluhovschi, G; Kaycsa, A; Petrica, L; Sporea, I; Velciov, S; Vernic, C | 1 |
| Chen, CH; Chuang, TW; Hu, TH; Hung, CH; Kuo, YH; Lee, CM; Lu, SN; Wang, JH | 1 |
| Alekseeva, LA; Bessonova, TV; Goriacheva, LG; Kotiv, MIa; Romantsov, MG; Vasil'eva, DK | 1 |
| Razonable, RR | 1 |
| Emara, MH; Radwan, MI | 1 |
| Jeong, SH; Kim, BH; Kim, YJ; Kim, YS; Lee, CK; Lee, JW; Park, CK; Park, SH; Yim, HJ | 1 |
| Chevaliez, S; Pawlotsky, JM; Rodriguez, C | 1 |
| Igarashi, T; Inoue, J; Kakazu, E; Kimura, O; Kobayashi, K; Kobayashi, T; Kondo, Y; Miura, M; Ninomiya, M; Shimosegawa, T; Tamai, K; Tanaka, Y; Ueno, Y; Yamamoto, T | 1 |
| Akarca, US; Akdogan, M; Boucher, CA; Ferenci, P; Flisiak, R; Hansen, BE; Janssen, HL; Pinarbasi, B; Raptopoulou-Gigi, M; Rijckborst, V; Simon, K; ter Borg, MJ; van Vuuren, AJ; Verhey, E | 1 |
| Biesta, PJ; Binda, RS; Boltjes, A; Boonstra, A; Janssen, HL; Op den Brouw, ML; van der Molen, RG; Woltman, AM | 1 |
| Azzouz, MM; El Bouchtili, S; Hamzaoui, L; Mahmoudi, M; Siai, K | 1 |
| Chen, CL; Chen, DS; Chen, PJ; Chuang, WL; Dai, CY; Kao, JH; Liu, CH; Liu, CJ; Peng, CY; Shen, YC; Su, TH; Tseng, TC; Yang, HC; Yu, ML | 1 |
| Chung, HJ; Kim, YS; Lee, JI; Lee, JW | 1 |
| Benhamou, Y; Cacoub, P | 1 |
| Hadziyannis, S; Koskinas, J; Manesis, E; Merkouraki, P | 1 |
| Myers, RP; Poynard, T; Thibault, V | 1 |
| Juárez Navarro, JA | 1 |
| Iino, S | 1 |
| Aprosina, ZG; Ignatova, TM; Il'iankova, AA; Krel', PE; Sekamova, SM; Serov, VV; Tanashchuk, EL | 1 |
| Maier, KP | 2 |
| Degertekin, H; Kilinc, N; Yalcin, K; Yildiz, F | 1 |
| del Mar Alcalde, M; Jiménez, C; Narváez, I; Pérez, B; Soria, A | 1 |
| Nishiguchi, S; Tamori, A | 1 |
| Mauss, S | 1 |
| Kakumu, S | 2 |
| Chang, WY; Chen, SC; Chuang, WL; Dai, CY; Hsieh, MY; Lee, LP; Lin, ZY; Wang, LY; Yu, ML | 1 |
| Chemin, I; Guillaud, O; Khattab, E; Mrani, S; Trepo, C; Vieux, C; Vuillermoz, I; Zoulim, F | 1 |
| Forestier, N; Friedrich-Rust, M; Zeuzem, S | 1 |
| Chao, YC; Chen, CL; Chen, DS; Chen, PJ; Hsiao, TJ; Hsieh, TY; Hu, JT; Kao, JH; Lai, MY; Liao, LY; Lin, CL; Liu, CJ; Yang, SS | 1 |
| Izumi, N | 1 |
| Chayama, K; Imamura, M | 1 |
| Müller, C | 1 |
| Buffet, C | 1 |
| Bani-Sadr, F; Chakvetadze, C; Lamontagne, F; Le Pendeven, C; Pialoux, G; Vincensini, JP | 1 |
| Brunetto, MR; Fargion, S; Gaeta, GB; Niro, GA; Picciotto, A; Pontisso, P; Raimondo, G; Saitta, C; Smedile, A; Squadrito, G | 1 |
| Pár, A; Szalay, F; Tornai, I | 1 |
| Bethanis, S; Christidou, A; Katsanika, A; Liapi, C; Manolakopoulos, S; Margeli, A; Sklavos, P; Stripeli, F; Theocharis, S; Tzourmakliotis, D; Vogiatzakis, E | 1 |
| Dybowska, D; Halota, W | 1 |
| Chamuleau, RA | 1 |
| Deterding, K; Manns, MP; Potthoff, A; Rifai, K; Trautwein, C; Wedemeyer, H | 1 |
| Berberat, PO; Encke, J; Gotthardt, D; Mehrabi, A; Merle, U; Riediger, C; Sauer, P; Stremmel, W; Weiss, KH | 1 |
| Jin, H; Piao, FS; Piao, XX; Ren, FY | 1 |
| Rockstroh, J; Vogel, M | 1 |
| Adachi, Y; Araki, J; Fujita, N; Horiike, S; Iwasa, M; Kaito, M; Kobayashi, Y; Mifuji, R; Sugimoto, R; Tanaka, H; Urawa, N; Yamamoto, M | 1 |
| Craxì, A | 1 |
| Dalekos, GN; Germenis, A; Liaskos, C; Makaritsis, K; Rigopoulou, EI; Togousidis, E; Zografos, TA | 1 |
| Dalmi, L; Gervain, J; Horváth, G; Hunyady, B; Ibrányi, E; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I | 1 |
| Ferenci, P; Staufer, K | 1 |
| Hsu, EK; Murray, KF | 1 |
| Arnold, J; Berg, T; Bergk, A; Boecher, WO; Deterding, K; Forestier, N; Gruengreiff, K; Kaeser, T; Manns, MP; Potthoff, A; Schuchmann, M; Spengler, U; Trautwein, C; Wedemeyer, H; Zeuzem, S | 1 |
| Canbakan, B; Mert, A; Ozaras, R; Ozbay, G; Senturk, H; Tabak, F; Tahan, V; Ulger, Y; Uraz, S | 1 |
| Coppola, N; Filippini, P; Imparato, M; Martini, S; Piai, G; Piccinino, F; Pisapia, R; Sagnelli, C; Sagnelli, E; Stanzione, M; Tonziello, G | 1 |
| Córdoba Cortijo, J; López Viedma, B; Olaso Peiró, V | 1 |
| Shneider, BL | 1 |
| Henrion, J | 1 |
| Rizzetto, M; Saracco, G | 1 |
| Böker, KH; Manns, MP | 1 |
| Carreño, V; Clouet, R; Cotonat, T; López-Alcorocho, JM; Manzarbeitia, F; Pardo, M; Quiroga, JA | 1 |
| Gordon, SC | 2 |
| Sterneck, M | 1 |
| Cote, P; Gerin, JL; Hornbuckle, W; Korba, BE; Tennant, BC | 1 |
| Galban-García, E; Gra-Oramas, B; Haedo-Castro, D; Jorge-Riaño, JL; Lorenzo-Morejon, I; Ramos-Sanchez, V; Rolo-Gómez, F; Soneiras-Perez, M; Vega-Sanchez, H | 1 |
| Doval Hernández, MA; Galban García, E; Gra Oramas, B; Haedo Castro, D; Lorenzo Morejón, I; Ramos Sánchez, V; Rodríguez Pérez, A; Rolo, F; Vega Sánchez, H | 1 |
| Füessl, HS | 1 |
| Carreño, V; Castañón, S; Esteban, JM; Pardo, M; Quiroga, JA; Rico, MA; Subirá, D | 1 |
| Keeffe, EB; Lin, OS | 1 |
| Pérez, R; Rodríguez, M | 1 |
| Gómez, M; Otero, A; Souto, J; Suárez, FJ; Vázquez-Iglesias, JL | 1 |
| Reddy, KR | 1 |
| Fried, MW; Sommadossi, JP | 1 |
| Arnold, JC; Stremmel, W | 1 |
| Cornberg, M; Manns, MP; Wedemeyer, H | 1 |
| Carreño, V; Pardo, M; Quiroga, JA; Rico, MA | 1 |
| Gow, PJ; Mutimer, D | 1 |
| Fukuda, Y; Hayashi, K; Nakano, I; Takamatsu, J; Toyoda, H | 1 |
| Matsushima, T | 1 |
53 review(s) available for ribavirin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Hepatitis C Virus and Hepatitis B Virus Co-Infection.
Topics: Animals; Antiviral Agents; Clinical Trials as Topic; Coinfection; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Interferons; Mice; Microbial Interactions; Ribavirin; Risk Factors; Virus Activation; Virus Replication | 2020 |
Impact of etiological treatment on prognosis.
Topics: Alcohol Abstinence; Antiviral Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon-alpha; Kidney Failure, Chronic; Liver Cirrhosis; Liver Diseases, Alcoholic; Liver Neoplasms; Liver Transplantation; Portal Pressure; Prognosis; Ribavirin | 2018 |
Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review.
Topics: Antiviral Agents; Disease Progression; Drug Therapy, Combination; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Ribavirin; Sustained Virologic Response; Viral Load; Vitamin D; Vitamin D Deficiency | 2018 |
Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
Topics: Antiviral Agents; Azathioprine; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prednisone; Recombinant Proteins; Recurrence; Ribavirin; Time Factors; Treatment Outcome | 2013 |
PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history.
Topics: Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2013 |
Review article: genetic factors that modify the outcome of viral hepatitis.
Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hepatitis B, Chronic; Hepatitis C, Chronic; HLA-DP alpha-Chains; HLA-DP beta-Chains; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Polyethylene Glycols; Polymorphism, Genetic; Recombinant Proteins; Ribavirin; Treatment Outcome | 2014 |
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.
Topics: Antiviral Agents; Coinfection; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Ribavirin; Treatment Outcome | 2014 |
Virus-related liver cirrhosis: molecular basis and therapeutic options.
Topics: Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Genotype; Hepacivirus; Hepatic Stellate Cells; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Inflammation; Interferon-alpha; Interferons; Interleukins; Killer Cells, Natural; Liver Cirrhosis; Mutation; Regeneration; Ribavirin; Stem Cells; Virus Replication | 2014 |
[Treatment of viral hepatitis in children].
Topics: Adenine; Adolescent; Antiviral Agents; Child; Child Welfare; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tenofovir | 2013 |
Interleukin 28B genetic polymorphism and hepatitis B virus infection.
Topics: Animals; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Genotype; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Host-Pathogen Interactions; Humans; Interferons; Interleukins; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Ribavirin; Treatment Outcome | 2014 |
Treatment of hepatitis B and C in children.
Topics: Adolescent; Antiviral Agents; Child; Drug Therapy, Combination; Egypt; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Infant; Interferon-alpha; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Treatment Outcome | 2014 |
Treatment of the hepatitis B virus and hepatitis C virus co-infection: still a challenge for the hepatologist.
Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2008 |
Management of patients co-infected with HBV and HCV.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Carrier State; DNA, Viral; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon Type I; Liver Cirrhosis; Liver Neoplasms; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Superinfection; Treatment Outcome | 2009 |
Cytokines - their pathogenic and therapeutic role in chronic viral hepatitis.
Topics: Antiviral Agents; Apoptosis; Cytokines; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatocytes; Humans; Interferon-alpha; Liver; Lymphocyte Subsets; Models, Biological; Receptors, Cytokine; Ribavirin; Virus Replication | 2009 |
Adverse effects of drugs in the treatment of viral hepatitis.
Topics: Antiviral Agents; Drugs, Investigational; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin; Risk Assessment; Risk Factors | 2010 |
Thymalfasin in the treatment of hepatitis B and C.
Topics: Adjuvants, Immunologic; Antiviral Agents; Europe; Hepacivirus; Hepatitis B; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Polyethylene Glycols; Polymerase Chain Reaction; Ribavirin; Thymalfasin; Thymosin; Viral Vaccines | 2010 |
[Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver Neoplasms; Ribavirin | 2010 |
Management of HIV and hepatitis virus coinfection.
Topics: Animals; Antiretroviral Therapy, Highly Active; Disease Management; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
New virologic tools for management of chronic hepatitis B and C.
Topics: Antiviral Agents; Clinical Trials as Topic; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Genome, Viral; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C Antigens; Hepatitis C, Chronic; Humans; Interferon-alpha; Oligopeptides; Point-of-Care Systems; Polyethylene Glycols; Proline; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Sequence Analysis, DNA; Treatment Outcome | 2012 |
[Role of interferons in the treatment of hepatitis B and hepatitis C virus infections].
Topics: Antiviral Agents; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin | 2002 |
[Treatment of chronic hepatitis C in patients coinfected with HIV-HCV/HBV].
Topics: Antiviral Agents; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Ribavirin | 2002 |
[Antiviral therapy for chronic viral hepatitis B and C].
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferon-beta; Lamivudine; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2003 |
[Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
Topics: Adenine; Adult; Antiviral Agents; Child; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Infant; Infant, Newborn; Interferons; Lamivudine; Liver Cirrhosis; Male; Mutation; Organophosphonates; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors | 2003 |
[Prevalence and clinical course in HBV and HCV dual chronic infection].
Topics: Adult; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Lamivudine; Male; Prevalence; Ribavirin; Superinfection | 2004 |
[Interferon therapy for chronic hepatitis B].
Topics: Antiviral Agents; Biomarkers; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Prognosis; Ribavirin | 2004 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Fatty Liver; Hemochromatosis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Interferons; Lamivudine; Liver Cirrhosis, Biliary; Liver Diseases; Organophosphonates; Prednisolone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors | 2005 |
[HCV-HBV infection].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk | 2006 |
Chronic Hepatitis B and C--current treatment and future therapeutic prospects.
Topics: Adenine; Antiviral Agents; DNA-Directed RNA Polymerases; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Organophosphonates; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin | 2006 |
[Acute hepatitis. Biological hepatic anomalies in asymptomatic persons].
Topics: Acute Disease; Adult; Antiviral Agents; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Diagnosis, Differential; France; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Hepatitis D; Hepatitis D, Chronic; Hepatitis, Viral, Human; Humans; Infectious Disease Transmission, Vertical; Interferon-alpha; Phosphoric Monoester Hydrolases; Prevalence; Ribavirin; Transaminases | 2006 |
[Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago].
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Drug Therapy, Combination; Fibroblasts; Hepatitis B, Chronic; Hepatitis C, Chronic; History, 20th Century; History, 21st Century; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferon-beta; Interferon-gamma; Interferons; Leukocytes; Lymphocytes; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Terminology as Topic | 2007 |
[Recent developments in the treatment of chronic hepatitis B and C].
Topics: Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Nucleosides; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
Topics: Antiviral Agents; Fibrosis; Hepatitis B, Chronic; Hepatitis, Chronic; Humans; Immunoglobulins; Interferons; Liver Transplantation; Polyethylene Glycols; Recurrence; Ribavirin; Treatment Outcome | 2007 |
Hepatitis B and C in children.
Topics: Antiviral Agents; Child; Disease Transmission, Infectious; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Infectious Disease Transmission, Vertical; Interferon-alpha; Lamivudine; Ribavirin; Treatment Outcome | 2008 |
[New antiviral agents in the treatment of chronic hepatitis B and C].
Topics: 2-Aminopurine; Antimetabolites; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lamivudine; Prodrugs; Reverse Transcriptase Inhibitors; Ribavirin | 1998 |
Treatment of chronic viral hepatitis.
Topics: Antiviral Agents; Glucocorticoids; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Patient Selection; Prednisone; Reverse Transcriptase Inhibitors; Ribavirin | 1999 |
[Chronic viral hepatitis caused by B and C virus: diagnostic and therapeutic trends].
Topics: Antiviral Agents; DNA, Viral; Genotype; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Lamivudine; Polymerase Chain Reaction; Recurrence; Ribavirin; RNA, Viral | 1999 |
[Therapy of chronic viral hepatitis].
Topics: Antiviral Agents; Germany; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; Hepatitis, Viral, Human; Humans; Interferons; Liver Transplantation; Prognosis; Renal Dialysis; Ribavirin; Risk Factors | 1999 |
Antiviral therapy for chronic hepatitis B and C. Which patients are likely to benefit from which agents?
Topics: Antiviral Agents; Contraindications; Drug Combinations; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Recombinant Proteins; Ribavirin | 2000 |
[Etiology of hepatocellular carcinoma. The problem of the primary disease].
Topics: Carcinoma, Hepatocellular; Cross-Cultural Comparison; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Ribavirin; Risk Factors | 2000 |
Is ribavirin treatment really effective for chronic hepatitis B?
Topics: Administration, Oral; Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Ribavirin; Treatment Outcome | 2000 |
Current treatment strategies for chronic hepatitis B and C.
Topics: Antiviral Agents; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Life Style; Recombinant Proteins; Ribavirin; Treatment Outcome; Vaccination | 2001 |
[Current treatment of chronic hepatitis B].
Topics: Antiviral Agents; Combined Modality Therapy; Contraindications; Hepatitis B, Chronic; Humans; Interferons; Liver Cirrhosis; Ribavirin; RNA, Viral | 2001 |
[Treatment of pretransplant and posttransplant viral cirrhosis].
Topics: Antiviral Agents; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Transplantation; Ribavirin; Secondary Prevention; Virus Replication | 2001 |
Transplantation for chronic hepatitis B and C: strategies for prevention and treatment of recurrent disease.
Topics: Antiviral Agents; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunoglobulins; Interferon-alpha; Liver Transplantation; Recurrence; Ribavirin | 2001 |
Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Combined Modality Therapy; Dideoxynucleosides; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Ribavirin; Vidarabine | 1996 |
[Chronic hepatitis--new therapeutic options].
Topics: Antiviral Agents; Contraindications; Drug Therapy, Combination; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Lamivudine; Polyethylene Glycols; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin | 2001 |
[PEG-interferons: significance for the treatment of viral hepatitis B and C].
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2001 |
Treatment of viral hepatitis--2001.
Topics: Antiviral Agents; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2001 |
Treatment of chronic hepatitis.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Ribavirin | 2001 |
[Impact of HIV on HCV, GBV-C/HGV, and HBV infection].
Topics: Anti-HIV Agents; Antibiosis; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Flaviviridae Infections; GB virus C; Hemophilia A; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; HIV Infections; HIV-1; Humans; Interferons; Lamivudine; Liver Neoplasms; Liver Transplantation; Prognosis; Ribavirin | 2002 |
[Treatment strategies for viral hepatitis].
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Lamivudine; Reverse Transcriptase Inhibitors; Ribavirin | 2002 |
14 trial(s) available for ribavirin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Precision Medicine; Recombinant Proteins; Ribavirin | 2015 |
Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; DNA Virus Infections; Drug Therapy, Combination; Female; Flaviviridae Infections; GB virus C; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Torque teno virus; Virus Diseases | 2008 |
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2010 |
Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2012 |
Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients.
Topics: Adult; Aged; Antiviral Agents; Dendritic Cells; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; T-Lymphocytes; Viral Load | 2013 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
Topics: Adult; Antiviral Agents; Drug Monitoring; Drug Resistance, Viral; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Male; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Predictive Value of Tests; Promoter Regions, Genetic; Ribavirin; Sequence Analysis, DNA; Viral Load; Young Adult | 2013 |
Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.
Topics: Adult; Anemia; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |
Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load; Virus Activation | 2006 |
An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.
Topics: Adolescent; Adult; Age Factors; Aged; Antiviral Agents; Biomarkers; Biopsy, Needle; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Lamivudine; Leptin; Liver Function Tests; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Recombinant Proteins; Reference Values; Ribavirin; Risk Factors; Severity of Illness Index; Sex Factors; Treatment Outcome | 2007 |
Ribavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B.
Topics: Adult; Aged; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferon-gamma; Interleukin-12; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Ribavirin; Th1 Cells; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Virus Replication | 2007 |
Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
Topics: Adult; Aged; Alcohol Drinking; Antiviral Agents; Disease Progression; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Iron; Iron Overload; Liver; Male; Middle Aged; Platelet Count; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Sex Factors; Transaminases; Treatment Outcome | 2007 |
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral | 2008 |
Efficacy of ribavirin in patients with chronic hepatitis B.
Topics: Administration, Oral; Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Biopsy; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Ribavirin | 2000 |
[Role of ribavirin in the treatment of chronic hepatitis B].
Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Ribavirin | 2000 |
63 other study(ies) available for ribavirin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Acute fulminant hepatitis B during hepatitis C virus therapy with direct-acting antivirals in a patient co-infected with HIV.
Topics: Anti-HIV Agents; Antiviral Agents; Benzimidazoles; Coinfection; Drug Substitution; Fatal Outcome; Fluorenes; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Liver Failure, Acute; Male; Middle Aged; Oligopeptides; Ribavirin; Sofosbuvir; Virus Activation | 2017 |
Hepatitis B reactivation in a patient with chronic hepatitis C treated with direct-acting antivirals.
Topics: Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Protease Inhibitors; Ribavirin; Ritonavir; Sulfonamides; Valine; Viral Load; Viral Nonstructural Proteins; Viremia; Virus Activation | 2018 |
Association of Interferon Alpha Receptor 1 with sustained virological response in hepatitis C and B co-infected patients.
Topics: Adult; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocytes, Mononuclear; Male; Middle Aged; Polyethylene Glycols; Prognosis; Receptor, Interferon alpha-beta; Recombinant Proteins; Ribavirin; RNA, Messenger; RNA, Viral; Sustained Virologic Response | 2017 |
NVR 3-778 Plus Pegylated Interferon-α Treatment for Chronic Hepatitis B Viral Infections: Could 1 + 1 = 3?
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2018 |
Bullous pemphigoid associated with chronic hepatitis C virus infection in a hepatitis B virus endemic area: A case report.
Topics: Administration, Oral; Aged; Antibodies, Viral; Antiviral Agents; Diagnosis, Differential; DNA, Viral; Glucocorticoids; Hepacivirus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Male; Methylprednisolone; Pemphigoid, Bullous; Republic of Korea; Ribavirin; Sofosbuvir; Treatment Outcome | 2018 |
Interferon alpha receptors and STAT1 as therapy predictors of a sustained virological response in hepatitis C/B co-infection.
Topics: Adult; Antibodies, Viral; Coinfection; Cross-Sectional Studies; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Polymerase Chain Reaction; Receptor, Interferon alpha-beta; Recombinant Proteins; Retrospective Studies; Ribavirin; STAT1 Transcription Factor | 2018 |
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma.
Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Phylogeny; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Failure; Viral Nonstructural Proteins | 2019 |
Hepatitis B virus and hepatitis C virus co-infection: a therapeutic challenge.
Topics: Antiviral Agents; Guanine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Ribavirin | 2013 |
Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C.
Topics: Antiviral Agents; Cohort Studies; DNA, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Viral Load; Virus Replication | 2013 |
Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Propensity Score; Recombinant Proteins; Registries; Retrospective Studies; Ribavirin; Survival Analysis; Treatment Outcome; Young Adult | 2014 |
Letter to the editor concerning the paper: Boltjes A, Op den Brouw ML, Biesta PJ, et al. Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients [Molecular Immunolog
Topics: Antiviral Agents; Dendritic Cells; Female; Hepatitis B, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Ribavirin | 2013 |
Treatment of patients with dual hepatitis B and C: a step in the right direction.
Topics: Antiviral Agents; Coinfection; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2014 |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.
Topics: Adult; Antiviral Agents; Biomarkers; Cell Line; Cross-Sectional Studies; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Mutation; Phenotype; Polyethylene Glycols; Prevalence; Promoter Regions, Genetic; Recombinant Proteins; Ribavirin; Taiwan; Time Factors; Transfection; Treatment Outcome; Viral Envelope Proteins; Viral Load | 2014 |
[EFFECTS OF URSODEOXYCHOLIC ACID IN STANDART INTERFERONTHERAPY OF PATIENTS WITH CHRONIC HEPATITIS C AND B].
Topics: Adult; Alkaline Phosphatase; Bilirubin; Female; gamma-Glutamyltransferase; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2015 |
Raynaud's phenomenon and bilateral olecranon bursitis co-existing in a patient with chronic hepatitis B and D treated with pegylated interferon.
Topics: Antiviral Agents; Bursitis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D; Humans; Interferon-alpha; Olecranon Process; Raynaud Disease; Recombinant Proteins; Ribavirin | 2016 |
[Treatment of chronic viral hepatitis].
Topics: Antibodies, Monoclonal; Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon-alpha; Ribavirin; Treatment Outcome | 2008 |
[Haematologic adverse effects of treatment of chronic viral hepatitis B and C].
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia | 2008 |
[Treatment of chronic hepatitis C: efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients].
Topics: Antiviral Agents; Combined Modality Therapy; Genotype; Hepacivirus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
[Spontaneous and treatment-induced virological dynamic in the plasma, PBMC and liver tissue in a patient with chronic HBV and HCV coinfection].
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B, Chronic; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocytes, Mononuclear; Liver; Liver Cirrhosis; Male; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load; Viremia | 2009 |
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.
Topics: Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
[Treatment of viral hepatitis in children].
Topics: Antiviral Agents; Child; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunization; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
[Response criteria].
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2005 |
Entering the new era of therapy for HBV and HCV infections.
Topics: Administration, Oral; Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Patient Selection; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2010 |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Female; Genotype; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Virus Activation | 2010 |
Peginterferon therapy for HBeAg-negative chronic hepatitis B: less than meets the eye.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Treatment Outcome | 2010 |
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis.
Topics: Adult; Antiviral Agents; Arthritis, Psoriatic; Drug Therapy, Combination; Etanercept; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunoglobulin G; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Latent Tuberculosis; Male; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Ribavirin | 2011 |
Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?
Topics: Adenine; Adult; Albuminuria; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors | 2011 |
Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy.
Topics: Antiviral Agents; Body Mass Index; Cholesterol; Drug Monitoring; Female; Genotype; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lipid Metabolism; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Research Design; Ribavirin; Risk Factors; Treatment Outcome; Triglycerides | 2011 |
[Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis].
Topics: Acridines; Adolescent; Antiviral Agents; Asymptomatic Infections; Biomarkers; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon Inducers; Interferon-alpha; Ribavirin; Treatment Outcome | 2011 |
Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient.
Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load; Virus Activation; Young Adult | 2011 |
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus.
Topics: Adult; Antiviral Agents; Cross-Sectional Studies; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy.
Topics: Adult; Amino Acid Sequence; Antiviral Agents; Case-Control Studies; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunity, Cellular; Interferon alpha-2; Interferon-alpha; Interferon-gamma; Lymphocyte Activation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2012 |
Hepatitis B virus and hepatitis C virus co-infection: a therapeutic challenge.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin | 2013 |
Prediction of sustained virologic response based on week 4 and week 12 response in hepatitis C virus genotype 1 patients treated with peginterferon and ribavirin: assessment in a favorable IL28B allele-prevalent area.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Genetic; Predictive Value of Tests; Prognosis; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2013 |
Assessment of depression in patients with chronic hepatitis: effect of interferon treatment.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Depression; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Ribavirin; Surveys and Questionnaires | 2002 |
The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Ribavirin; RNA, Viral | 2003 |
[Chronic viral hepatitis].
Topics: Adult; Age Factors; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Clinical Enzyme Tests; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Prognosis; Retrospective Studies; Ribavirin; Risk Factors; Sex Factors; Time Factors | 2003 |
A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Recurrence; Ribavirin; Virus Activation | 2003 |
Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease.
Topics: Adult; Celiac Disease; Diabetes Mellitus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Function Tests; Male; Prognosis; Ribavirin; Risk Assessment | 2003 |
[Progress in the treatment of hepatitis B and C co-infection in HIV patients].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Survival Rate | 2004 |
Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Topics: Adult; Antiviral Agents; Case-Control Studies; DNA, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon Type I; Male; Middle Aged; Recombinant Proteins; Ribavirin; Viral Interference | 2005 |
Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
Topics: Adult; Amantadine; Amino Acid Sequence; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; France; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Sequence Alignment; Sequence Analysis, DNA; Viral Load | 2005 |
[Treatment of viral hepatitis in children].
Topics: Child; Drug Therapy, Combination; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin | 2005 |
[Perspectives in hepatology in the next 2-3 years: what will be clinically relevant? Viral hepatitis].
Topics: Amantadine; Antiviral Agents; Genotype; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatovirus; Humans; Interferons; Nucleic Acid Synthesis Inhibitors; Protease Inhibitors; Ribavirin; Viral Load | 2005 |
[How to use viral genomic analysis in clinical practice: chronic hepatitis B and C].
Topics: Adult; Genome, Viral; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2006 |
Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies.
Topics: Adult; Antiviral Agents; Female; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Virus Activation | 2007 |
[Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hungary; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Treatment Outcome | 2007 |
[Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
Topics: Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Prognosis; Ribavirin | 2007 |
[Treatment with natural interferon (alfaferone) in clinical practice--our experience].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Treatment Outcome | 2007 |
Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2007 |
Highlights of the third international workshop on HIV and hepatitis coinfection.
Topics: Antiretroviral Therapy, Highly Active; Hepatitis B, Chronic; Hepatitis C; Hepatitis, Viral, Human; HIV Infections; Humans; Interferons; Ribavirin | 2007 |
Introduction. Necroinflammation and the course of chronic hepatitis.
Topics: Antiviral Agents; Congresses as Topic; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Inflammation; Interferon alpha-2; Interferon-alpha; Liver; Necrosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Topics: Adiponectin; Adult; Antiviral Agents; Biomarkers; Body Mass Index; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; RNA, Viral; Tumor Necrosis Factor-alpha | 2008 |
[Protocol for the treatment of chronic viral hepatitis].
Topics: Adenine; Algorithms; Antiviral Agents; Clinical Protocols; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
Topics: Antiviral Agents; Depressive Disorder; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Chronic; Humans; Interferons; Liver Function Tests; Male; Ribavirin; Risk Assessment; Severity of Illness Index | 2008 |
Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral | 2008 |
Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocytes, Mononuclear; Liver; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral | 2008 |
Pediatric drug trials: women and children last?
Topics: Adult; Antiviral Agents; Child; Clinical Trials as Topic; Drug Approval; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Hepatitis C; Humans; Interferon-alpha; Patient Selection; Ribavirin; United States; United States Food and Drug Administration | 1999 |
Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
Topics: Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Mutation; Pilot Projects; Recombinant Proteins; Retreatment; Ribavirin; Treatment Outcome | 2000 |
Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Famciclovir; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Humans; Marmota; Ribavirin; Vidarabine Phosphate; Virus Replication; Zidovudine | 2000 |
[Chronic viral hepatitis: guidelines for diagnosis and therapy. When to treat--when wait?].
Topics: Drug Monitoring; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Prognosis; Ribavirin | 2000 |
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Cell Division; Cytokines; Drug Therapy, Combination; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Monocytes; Ribavirin; T-Lymphocytes | 2001 |
Extended follow-up of anti-HBe-positive patients with chronic hepatitis B retreated with ribavirin and interferon-alpha.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon Type I; Male; Middle Aged; Pilot Projects; Ribavirin | 2001 |